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Regulation of mouse podocyte process dynamics by protein The foot processes of podocytes establish the filtration
tyrosine phosphatases. Rapid Communication. slits for glomerular filtration by decorating the external
Background. Effacement of podocyte foot processes occurs part of the glomerular basement membrane (GBM) inearly in many glomerular diseases associated with proteinuria
a characteristic interdigitating pattern with foot pro-and is accompanied by a reorganization of the actin cytoskele-
cesses of neighboring cells [1]. On their luminal surface,ton. The molecular mechanisms regulating these structural
changes are poorly understood. podocytes are equipped with a negatively charged glyco-
Methods. To address these questions, we analyzed the effect calyx, which is formed by anionic sites of sialoglycopro-
of the polycation, protamine sulfate (PS), and puromycin
teins, of which podocalyxin is the major component [2, 3].aminonucleoside (PA) on the morphology, cytoskeleton, and
This surface coat contributes to the negative charge oftyrosine phosphorylation of differentiated process-bearing cul-
tured podocytes. the filtration barrier and is of critical importance for the
Results. PS and PA induced similar profound morphological preservation of the specific cell architecture of podocytes
alterations, including retraction and detachment of podocyte [3, 4]. The foot processes of podocytes are connected toprocesses from the extracellular matrix (ECM). The effects of
the GBM primarily via a3b1 integrin [5, 6].PS occurred within six hours, whereas PA showed its most
Effacement of podocyte foot processes occurs earlysevere effects after 72 hours. Structural changes included reor-
ganization of the actin cytoskeleton and focal contacts and in many glomerular diseases, independent of the under-
were accompanied by an increase in tyrosine phosphorylation. lying cause, and is closely correlated with the develop-
The same effects were induced by application of vanadate, an
ment of proteinuria [7]. Experimentally, foot processinhibitor of protein tyrosine phosphatases (PTPs), suggesting
effacement and subsequent proteinuria can be inducedthat PTPs regulate podocyte process structure. Since disruption
of the actin cytoskeleton with cytochalasin B protected the by several maneuvers, such as cross-linking of b1 integrins
cells from PS-induced effacement and detachment, cytoplasmic with a b1 integrin-specific antibody [8]. Genetically, foot
PTPs were implicated in these events. Using reverse transcrip- process fusion can be induced by inactivation of eithertion-polymerase chain reaction (RT-PCR), we demonstrated
the a3 integrin gene [6] or the s-laminin/laminin b2 genethe expression of four cytoplasmic PTPs in podocytes: SHP-2,
[9]. Foot process fusion can also be induced by perfusionPTP-PEST, PTP-1B, and PTP-36.
Conclusions. These studies indicate an important role for of rat renal arteries with polycations such as protamine
cytoplasmic PTPs as regulators of podocyte process dynamics. sulfate (PS) [10, 11] and by the administration of the
Future studies will aim at restoring the normal foot process
podocyte toxin puromycin aminonucleoside (PA) [12, 13].architecture of podocytes in glomerular diseases associated
The molecular signaling pathways regulating thesewith proteinuria by modulating the activity of cytoplasmic PTPs.
morphological alterations of podocytes are poorly un-
derstood [7]. To unravel these mechanisms, we analyzed
the effects of PS and PA on morphology, actin cytoskele-
ton, and tyrosine phosphorylation of differentiated cul-Key words: focal contacts, nephrotic syndrome, protamine sulfate, pu-
romycin aminonucleoside. tured podocytes that share many structural and func-
tional characteristics of podocytes in vivo [14, 15]. WeReceived for publication November 19, 1999
now provide evidence that continuous tyrosine dephos-and in revised form January 26, 2000
Accepted for publication February 1, 2000 phorylation of podocyte proteins by cytoplasmic protein
tyrosine phosphatases (PTPs) is required to maintain theÓ 2000 by the International Society of Nephrology
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normal process architecture and attachment of podo- H2O2 or vanadate alone. PTKs were inhibited with the
erbstatin analogue 2,5-dihydroxymethylcinnamate (2,5-cytes to the underlying extracellular matrix (ECM).
Mec; Calbiochem, La Jolla, CA, USA). Differentiated
podocytes were treated with either 2,5-Mec alone in dif-
METHODS ferent concentrations (1 to 20 mmol/L) or in the presence
Cell culture of podocytes of PS. Coincubation of heparin (500 U/mL; Sigma) and
PS was carried out to exclude toxic effects of PS. Again,Cultivation of podocytes was carried out as reported
NIH3T3 fibroblasts were used as a control with identical[15]. In brief, podocytes were maintained in RPMI 1640
experimental procedures as those described for podocytes.medium (Life Technologies, Grand Island, NY, USA)
supplemented with 10% fetal calf serum (FCS), 100 U/mL Reverse transcription-polymerase chain reaction
penicillin, and 100 mg/mL streptomycin. To propagate
Total RNA was isolated from differentiated culturedpodocytes, the culture medium was supplemented with
podocytes (untreated or treated with 50 mg/mL PA for
10 U/mL mouse recombinant g-interferon (Sigma, St. 48 hours) using the RNeasy Kit (Qiagen, Chatsworth,
Louis, MO, USA) to enhance expression of the T antigen, CA, USA) according to the manufacturer’s instructions,
and cells were cultivated at 338C (permissive conditions). Reverse transcription (RT) and RT-polymerase chain
To induce differentiation, podocytes were cultured on reaction (PCR) were performed as described [16]. As a
type I collagen at 378C without g-interferon (nonpermis- negative RT-PCR control, cDNA was omitted. The cDNA
sive conditions) for at least 14 days. reaction mix from RT minus reactions and water controls
was consistently negative (data not shown). For detec-
Immunocytochemistry tion of various PTPs, the following sequence-specific
Primary antibodies specific for the following anti- primers were designed according to published sequences
gens were used in the present study: a-tubulin (mouse [17–22] and our own unpublished results:
monoclonal; Oncogene Research Products, Cambridge,
PTP-PEST:MA, USA), phosphotyrosine (mouse monoclonal, clone
59,59-GCGGACTGTAGTGCGGCTCATTCA-39PY20; Transduction Laboratories, Lexington, KY, USA),
39,59-TGCGGCGTGCCTGCTACTTCCTGT-39and vinculin (mouse monoclonal; Boehringer Mannheim,
SHP-2:Mannheim, Germany). In addition, FITC-conjugated pha-
59,59-CTCAAGCAGCCCCTCAACACAA-39lloidin (Sigma) was used to label actin filaments. The
39,59-GAACACCATCCGCCAGAAGTCAT-39immunolabeling and confocal microscopy was carried PTP1B:
out as described [15]. Antigen-antibody complexes were 59,59-CCCGGCCACCCAAACGCACACT-39
visualized with fluorochrome (Cy2 or Cy3)-conjugated 39,59-GACGCCGCAGACCGCATCCTAAGC-39
secondary antibodies (Rockland, Gilbertville, PA, USA). PTEN:
Some preparations were incubated with a mixture of a 59,59-CCGGCGCAGGCGAGGGAGATG-39
secondary antibody and FITC-conjugated phalloidin. 39,59-CGAGGCAGCGGAATGGGGAGAAGA-39
PTP36:
Application of protamine sulfate and 59,59-GCGGCGGTGGCACGGTGAATAAAC-39
puromycin aminonucleoside 39,59-GAGACACTGAGGGCCTTGGATGGT-39
Protamine sulfate (600 mg/mL) was applied for one PTP20:
to eight hours to podocytes, which had been grown at 59,59-TCGCCACTCTTCTCCCCATACACC-39
nonpermissive conditions for at least 12 days. PA was 39,59-AGTTCAAGACGGGCATTCCAAGAG-39
SHP-1:used at 50 mg/mL for 24 to 96 hours. The cells were then
59,59-GGGAATTCCCACCAGTGAGAGGTGGprocessed for phase-contrast microscopy and immunocy-
TACCA-39tochemistry. NIH3T3 fibroblasts were used as a control.
39,59-CCCAAGCTTGAAGCAGGTAGACAAA
Modulation of tyrosine phosphorylation GGCAC-39
To study the effects of tyrosine phosphorylation on Normalization of the PCR reactions was performed
podocyte processes, we used inhibitors of PTPs and pro- with primers for the housekeeping enzyme GAPDH.
tein tyrosine kinases (PTKs). To block PTPs, cells were
incubated for 15 minutes in serum-free medium supple-
RESULTSmented with 0.4 mmol/L H2O2 and 40 mmol/L sodium
PS and PA induce process retraction andvanadate. The cells were rinsed twice and then cultivated
reorganization of the actin cytoskeleton andfor one to four hours with standard medium containing
increased tyrosine phosphorylation10% FCS before processing for immunocytochemistry
and phase contrast microscopy. To exclude toxic effects, Podocytes were treated with PS and PA and analyzed
by light microscopy and immunocytochemistry (Figs. 1–4).the cells were incubated in some experiments with either
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Figs. 1–4. Modulation of podocyte morphology, actin cytoskeleton, focal contacts, and tyrosine phosphorylation by protamine sulfate (PS),
puromycin aminonucleoside (PA), and vanadate.
Fig. 1. Control cells show well-developed processes (a) and contain long bundles of actin filaments that terminate in the periphery of the cell
processes (b). Focal contacts as revealed by vinculin staining are mainly located at the cell periphery and the tips of the processes (c) and represent
the major sites of tyrosine phosphorylation (d), as demonstrated by double labeling experiments (data not shown; 3400).
Fig. 2. PS treatment induced process retraction and cell rounding by six hours (a) with a loss of actin filament bundles (b). Vinculin staining
revealed a marked reduction in the number and a redistribution of focal contacts (c), and tyrosine phosphorylation levels were significantly
increased in the cytoplasm (d; 3400).
Fig. 3. PA treatment induced process retraction and cell rounding by 72 hours (a) with a similar loss of actin filaments (b) and focal contact
alterations (c). As observed for PS, tyrosine phosphorylation levels were significantly increased in the cytoplasm, but were reduced in the focal
contacts (d; 3400).
Fig. 4. Vanadate treatment for two hours induced the same effects as PS and PA, including process retraction, cell rounding and detachment (a),
loss of actin filament bundles (b), focal contact number reduction, and redistribution (c). An increased tyrosine phosphorylation could be detected
within the cytoplasm of podocytes (d; 3400).
Application of PS led to dramatic cellular effects. After (Fig. 1b). In untreated podocytes, phosphotyrosine im-
munofluorescent staining revealed that tyrosine-phos-six hours, most processes were retracted and most cells
had detached from the culture dish (Fig. 2a). Vinculin phorylated proteins were found mainly in focal contacts
(Fig. 1d). After treatment with PS, enhanced stainingstaining of focal contacts demonstrated a marked reduc-
tion in focal contact number and altered focal contact for tyrosine-phosphorylated proteins could be observed
in the cytoplasm (Fig. 2d).location in PS-treated cells (Fig. 2c) compared with con-
trol cells (Fig. 1c). Using fluorochrome-labeled phalloi- The effects of PA on morphology, actin cytoskeleton,
focal contacts, and tyrosine phosphorylation were com-din to visualize alterations of the actin cytoskeleton, actin
filament bundles were shown to be reduced in PS-treated parable to those of PS (Fig. 3). As has been shown in
vivo [12, 13], the PA effects had a slower time coursepodocytes (Fig. 2b) compared with untreated podocytes
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compared with PS, the minimum time period required Expression of cytosolic PTPs in untreated and
PA-treated podocytesfor the onset of process retraction being 48 hours. By
72 hours, almost all processes had retracted (Fig. 3a). To identify candidate PTPs mediating podocyte process
attachment, we used RT-PCR to investigate the mRNA
Effects of PS and PA can be mimicked by vanadate expression of various cytosolic PTPs in differentiated
cultured podocytes. As shown in Figure 7, SHP-2 (lane 2),Blocking of PTPs with vanadate, a PTP inhibitor, re-
PTP-PEST (lane 3), PTP1B (lane 4), and PTP-36 (lane 5)sulted in process retraction and detachment of podocytes
were all expressed in both untreated and PA-treatedfrom the culture dish within two to four hours (Fig. 4a).
podocytes. The yield of SHP-2 PCR product showed aResults of a two-hour treatment showed that actin fila-
significant increase in PA-treated cells, whereas PTP-ments were disassembled (Fig. 4b), focal contacts were
PEST and PTP1B remained unchanged. PTP-36 showedreduced in number (Fig. 4c), and there was a dramatic
a possible decrease in expression levels. SHP-1 (lane 1),increase of cytoplasmic tyrosine phosphorylation (Fig.
PTEN, and PTP20 expression was not detected in podo-4d). In contrast, after inhibition of PTKs with the erbs-
cytes.
tatin analogue 2,5-Mec, there was no significant change
in cell morphology within six hours, despite an overall Effects of PS and PA are specific for podocytes
reduction of P-Tyr staining (data not shown). Moreover, To test whether the observed effects of PS and PA on
blocking of PTKs with 2,5-MeC did not prevent the ef- the cellular morphology were specific for podocytes or
fects of PS (data not shown). These results indicate that simply due to general cellular cytotoxicity, we performed
reduced activity of PTPs rather than increased activity of control experiments with NIH3T3 fibroblasts. Neither
PTKs led to process retraction and podocyte detachment substance significantly affected the morphology of these
from the ECM. cells, and no rounding up nor detachment was observed.
However, vanadate treatment led to the detachment of
Reorganization of the actin cytoskeleton precedes NIH3T3 fibroblasts (data not shown), suggesting that
process retraction of podocytes while the downstream intracellular signaling pathways
leading to process retraction and cell detachment mayTo analyze the early events of cytoskeletal reorgani-
be shared between fibroblasts and podocytes, upstreamzation after tyrosine hyperphosphorylation, cells were
PS- and PA-induced signaling pathways appear to beexamined by phase-contrast microscopy and immunocy-
specific to podocytes.tochemistry for actin and tubulin 90 minutes after treat-
ment with vanadate (Fig. 5). By this time, the cells were
still attached to the ECM, but the processes were shrunk DISCUSSION
(Fig. 5d), displaying a morphology comparable to that The results of the present study suggest that the pro-
of cytochalasin B-treated cells with disrupted actin fila- cess dynamics and attachment of podocytes to the ECM
ments (Fig. 6e). Phalloidin labeling revealed that stress may be regulated by tyrosine phosphatases. Evidence
fibers had disappeared and the actin cytoskeleton was for this includes the following: (1) PS- and PA-induced
depolymerized (Fig. 5e). In contrast, staining for a-tubulin process retraction and podocyte detachment were ac-
companied by an increase in cellular tyrosine phosphory-revealed intact microtubule bundles in the well-preserved
lation. (2) Vanadate, a PTP inhibitor, produced identicalmajor processes (Fig. 5f).
effects, while a PTK inhibitor had no effect on podocyte
morphology. (3) Moreover, PTK inhibition did not pro-PS-induced detachment of podocyte processes
tect against PS-induced process retraction and detach-requires an intact actin cytoskeleton
ment. Further results indicate that the PS-induced effectSince the activity of some cytoplasmic PTPs is depen-
is dependent on an intact actin cytoskeleton, indicatingdent on an intact actin cytoskeleton [23], we depolymer-
that the PTPs mediating this effect are cytosolic. Podo-
ized the actin filaments with cytochalasin B before treat-
cytes express at least four cytoplasmic PTPs: SHP-2,
ment with PS. Application of PS resulted in process PTP-PEST, PTP1B, and PTP-36, which have been shown
retraction and detachment in cells with either an intact to play a role in the regulation of focal contact dynamics
cytoskeleton (Fig. 6b) or with disrupted microtubules [18–22, 24–26].
but intact actin (Fig. 6d). In contrast, podocytes with a Infusion of positively charged substances like PS into
disrupted actin cytoskeleton but normal microtubules rat renal arteries results in fusion of foot processes, prob-
were not affected by PS (Fig. 6f). These findings support ably caused by the neutralization of the negative surface
the idea that the effects of PS on podocytes are mediated charge [10], and is accompanied by complex changes in
by cytoplasmic PTPs that may require actin filament- intracellular phosphorylation [11]. Similarly, the process
retraction of cultured podocytes induced by PS and PAmediated transport to their site of action.
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Fig. 5. Disassembly of the actin but not microtubular cytoskeleton precedes process retraction. (Left panel, a–c) Control cells. (Right panel, d–f )
Cells treated for 90 minutes with vanadate. The early changes in podocyte process morphology after inhibition of PTPs are shown. Control cells
show well-developed processes (a) and long bundles of actin filaments terminally in the periphery of the cell processes (b). The major processes
contain microtubles as revealed by double labeling of the same cells with a-tubulin (c). After vanadate treatment, podocyte processes are shrunk
(d) but still attached to the ECM (arrowheads). In these cells, the processes are devoid of actin filaments (arrowheads in e), but are supported
by microtubules, as revealed by double labeling (arrowheads in f; a–f, 3600).
is accompanied by a dramatic increase and subcellular tion of PTKs. However, vanadate was used as a PTP
inhibitor during the isolation of PS- and PA-treated glo-redistribution of tyrosine phosphorylation (Figs. 2 and 3).
Associated with the increase in cytoplasmic tyrosine phos- meruli in the previous study, which could mean that the
hyperphosphorylation was also mediated by inhibitionphorylation is a reduction in tyrosine phosphorylation at
focal contacts. In contrast to a previous in vivo study of PTPs in that study. The possibility that PTPs rather
than PTKs are important in the regulation of podocyte[11], the present study revealed that the observed process
effacement and the associated hyperphosphorylation process dynamics is supported by the observation that
inhibition of PTKs by an erbstatin analogue could notwere mediated by the inhibition of PTPs, not by an activa-
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Fig. 6. An intact actin cytoskeleton is required to mediate the effects of PS. Cells with intact actin and microtubular cytoskeleton (a and b).
Selective depolymerization of microtubules with colcemid (c and d ) and selective depolymerization of actin filaments with cytochalasin B (e and
f ). The cells with an intact cytoskeleton (b) or with a selective disruption of microtubules only (d) respond to PS with process retraction and
detachment. In contrast, the cells with a disrupted actin cytoskeleton no longer respond to PS and remain attached to the substrate ( f ; a–f, 3600).
prevent the PS-induced process retraction and cell de- ture of podocyte foot processes by maintaining substrate
phosphoproteins in a dephosphorylated state.tachment. Moreover, the effect of PS was dependent on
an intact actin cytoskeleton, which is required for the It is unclear at this point which PTP(s) mediates the
observed effects. We have identified four cytosolic PTPsactivity of certain PTPs [17]. Thus, cytoplasmic PTPs
appear to be important in preserving the normal architec- expressed in podocytes, one of which (SHP-2) appeared
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Fig. 7. Podocyte mRNA expression pattern
of cytosolic PTPs using RT-PCR of RNA ob-
tained from untreated (left panel) and PA-
treated cells (right panel). Products of the ex-
pected size for the cytosolic PTPs SHP-1 (lane
1), SHP-2 (lane 2), PTP-PEST (lane 3), PTP-
1B (lane 4), and PTP-36 (lane 5) were amp-
lified. SHP-1 was not expressed under both
conditions. In PA-treated cells, SHP-2 expres-
sion was up-regulated, while PTP-PEST and
PTP-1B were unchanged. The levels of PTP-36
expression appeared to be down-regulated.
Normalizaton of the PCR reaction was per-
formed with primers for the housekeeping en-
zyme GAPDH (lane 6).
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